What happens after the procedure
The peptides frequently being referenced in reclassification conversations include: AOD-9604 BPC-157 Emideltide (DSIP Delta Sleep-Inducing Peptide) Epitalon (Epithalamin) GHK-Cu (Copper Peptide) Kisspeptin-10 KPV MOTS-C Semax Selank TB-500 (Thymosin Beta-4 Fragment) Thymosin Alpha-1 Despite public discussion, these peptides remain categorized as Category 2 under current FDA policy and are not eligible for patient-specific 503A compounding
Not sure which BPC-157 protocol fits your goal
10.1007/s13346-018-00613-y 6 BolamanZ.KadikoyluG.YukselenV.YavasogluI.BarutcaS.SenturkT
Bacteriostatic water for injection allows the administration of medications through different parenteral (outside the gut) routes , such as intravenous (into the veins), intramuscular (into the muscles), and subcutaneous (under the skin) routes
Key Features 10mg total: 5mg BPC 157 + 5mg TB500 per sterile vial Purity cannot be tested on blend peptides, Individual compound tests for purity can be found on the COA page Lyophilized powder form for stable storage Manufactured in ISO-compliant lab facility Research Applications This peptide blend is studied for its potential in enhancing cellular regeneration, reducing inflammation, and supporting tissue repair in laboratory models